
|

| |
Track the *RXGNE Index |
 |
|
 | Genetic Analysis Stocks (*RXGNE) |
| |
Genetic Analysis Ideas |
|
|
|
Genetic Analysis Performance |
|
|
|
Genetic Analysis Community |
|
| |
|
Index Description: Firms involved in the burgeoning field of genetic analysis and testing
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.3%
+21.6%
+18.1%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.4%
+17.3%
-1.6%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$2.0B
57.6
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| AFFX |
$3.67 |
-0.01 |
-0.3% |
376,126 |
58% |
$260.9M |
- |
24% |
-33% |
No Alerts/News
|
|
|
| EXAS |
$10.69 |
+0.15 |
+1.4% |
276,189 |
12% |
$685.1M |
- |
54% |
-13% |
1 Alert (0 News) - View
|
|
|
| GHDX |
$37.00 |
0.00 |
0.0% |
163,918 |
64% |
$1.1B |
- |
47% |
-2% |
No Alerts/News
|
|
|
| [GNOM] |
$0.00 |
0.00 |
0.0% |
|
0% |
$ |
- |
N/A% |
N/A% |
No Alerts/News
|
|
|
| ILMN |
$70.31 |
-0.77 |
-1.1% |
1,111,968 |
63% |
$8.7B |
- |
86% |
-9% |
1 Alert (0 News) - View
|
|
|
| LMNX |
$19.11 |
+0.15 |
+0.8% |
137,054 |
64% |
$780.4M |
- |
24% |
-26% |
No Alerts/News
|
|
|
| MYGN |
$31.43 |
-0.76 |
-2.4% |
1,104,565 |
83% |
$2.5B |
- |
43% |
-9% |
No Alerts/News
|
|
|
| NSPH |
$4.26 |
+0.47 |
+12.4% |
2,175,255 |
393% |
$238.9M |
- |
161% |
10% |
3 Alerts (0 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
UK to Pilot Illumina Genetic Test for Breast, Ovarian Cancer MYGN ILMN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 20, 10:07AM from (www.bloomberg.com) The U.K. is piloting a new genetic test developed by Illumina Inc. (ILMN) to help cancer patients and their doctors better
Flag
Post a comment
Affymetrix Appoints Gavin Wood as Executive Vice President and Chief Financial Officer AFFX
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 20, 06:00AM from (www.businesswire.com) Affymetrix, Inc. (NASDAQ: AFFX) today announced it has appointed Mr. Gavin Wood to the position of Executive Vice President
Flag
Post a comment
Company That Sells Angelina Jolie’s Blood Test MYGN MON
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 15, 03:18PM from (ycharts.com) Shares of Myriad Genetics (MYGN) spiked higher yesterday to hit their highest levels on record since mid-2009, as seen in
Flag
Post a comment
Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits ILMN
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 15, 06:30AM from (www.businesswire.com) Illumina, Inc. (NASDAQ:ILMN) today announced it is collaborating with leading providers of liquid handling robotic platforms
Flag
Post a comment
Roche Wins FDA Approval for Test to Target Lung Cancer MYGN QGEN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 05:43PM from (www.bloomberg.com) Roche Holding AG (ROG), the world’s biggest maker of cancer drugs, won U.S. approval to sell a gene mutation test that
Flag
Post a comment
Myriad Genetics, Angelina Jolie, and Genomics in Focus MYGN GHDX ROSG
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 14, 01:58PM from (247wallst.com) Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic
Flag
Post a comment
Myriad Genetics to Present at the Bank of America Merrill Lynch Health Care Conference MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 07:13AM from (globenewswire.com) SALT LAKE CITY, May 14, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum,
Flag
Post a comment
Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics BDX DHR XRAY MYGN A ALGN NSPH OSUR EXAS
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 13, 08:00AM from (247wallst.com) In theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really
Flag
Post a comment
Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 07, 04:13PM from (globenewswire.com) SALT LAKE CITY, May 7, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its third
Flag
Post a comment
Myriad Genetics Announces 2013 Analyst and Investor Day MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 02, 04:13PM from (globenewswire.com) SALT LAKE CITY, May 2, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that its Analyst and
Flag
Post a comment
PropThink Analyst Finds Five Cheap Biotech Stocks to Buy ENDP ILMN KERX EXAS AVEO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 01, 08:40AM from (247wallst.com) Biotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but
Flag
Post a comment
Affymetrix Reports 2013 First Quarter Results AFFX
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 30, 04:00PM from (www.businesswire.com) Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three months ended March 31, 2013. Results
Flag
Post a comment
|
|
|